Perceptions of professionals regarding interventions involving family members responsible for justice-involved youth with substance use disorders in Santiago, Chile.

Abstract

BackgroundEliciting professionals’ experiences of current drug treatment programmes can lead to improvements of these youth-centred programmes through the involvement of the concerned youths’ families. We explored perceived barriers amongst professionals concerning interventions incorporating parents or guardians responsible for justice-involved youth with substance use disorders. MethodsWe conducted semi-structured in-depth interviews with fourteen female and four male professionals, each representing one of eighteen programmes under the Chilean National Drug Treatment Programme (2016–2017), who were tasked with contacting and/or intervening in the families of justice-involved youth. Subsequently, we performed traditional content analysis. ResultsThe professionals identified four key barriers impeding interventions: (1) parents’ non-adherence to the treatment and issues relating to their role fulfilment; (2) tensions within the programme design that constrain the families’ involvement in the interventions; (3) the lack of a supportive professional network offering interventions that complement drug treatment; (4) the problematic and dangerous living contexts of these families that discourage family involvement. Additionally, professionals identified intervention needs for improving treatment outcomes. ConclusionsThe negative perceptions of professionals regarding the interventions as well as families and family contexts of justice-involved youth, and the lack of support from other programmes, induced feelings of hopelessness and pessimism amongst the professionals regarding the effectiveness of the Chilean National Drug Treatment Programme. It is essential to consider professionals’ perspectives not only to benefit from their expertise, but also to assess whether their perspectives may hinder the implementation of changes when attempting to innovate drug treatment modalities aimed at improving their outcomes.